Monica Bertagnolli and Brett Guthrie named Friends 2024 Cancer Leadership Award recipients

As Trump’s second term nears, Republican support for NIH is at a low point
By stonewalling GOP in the House, Biden’s HHS officials eroded bipartisan support for biomedical research

The Biden administration has left NIH in a weakened state, intensifying politicization of science on Capitol Hill and eroding the bipartisan support the government’s premier biomedical research agency has traditionally enjoyed.

As Trump’s HHS pick, RFK Jr. stands to honor or squander the Kennedy legacy in cancer

President-elect Donald Trump said he would nominate Robert F. Kennedy Jr. to the post of secretary of the Department of Health and Human Services, placing the vaccine skeptic in charge of a vast empire of research, engineering, regulatory, and health care agencies.

What will Trump’s return to the White House mean for oncology?
“Our work just got a lot more difficult.”

On Nov. 5, as the American people expressed their will, electing Donald Trump to a second term, I started to wonder what my friends in oncology were thinking.

Trump 2016: A look back at the 45th president’s impact on oncology

As oncology contemplates the potential impact of a second Donald Trump term on cancer care and research, The Cancer Letter has compiled a list of guest editorials, news analyses, and data-driven reports that this magazine published during his first term.

November 08, 2024

Vol.50 No.42

By Katie Goldberg and Claire Marie Porter

In the Archives

New exhibit: Presidential elections and tobacco

In a new online exhibition, The University of Alabama Center for the Study of Tobacco and Society spotlights tobacco advertisements and promotional artifacts from presidential election campaigns.

October 25, 2024

Vol.50 No.40

How the 2024 elections can impact cancer policy

As we come within a stone’s throw of Nov. 5, we can’t help but wonder if and how the election outcome will impact health care policy, and cancer policy in particular.

October 18, 2024

Vol.50 No.39

By Samyukta Mullangi and Debra Patt

Monica Bertagnolli and Brett Guthrie named Friends 2024 Cancer Leadership Award recipients

YOU MAY BE INTERESTED IN

As Trump’s second term nears, Republican support for NIH is at a low point
By stonewalling GOP in the House, Biden’s HHS officials eroded bipartisan support for biomedical research

As Trump’s HHS pick, RFK Jr. stands to honor or squander the Kennedy legacy in cancer

What will Trump’s return to the White House mean for oncology?
“Our work just got a lot more difficult.”

Trump 2016: A look back at the 45th president’s impact on oncology

New exhibit: Presidential elections and tobacco

How the 2024 elections can impact cancer policy

Renew today!

Subscriber content

Never miss an issue!

Login

Monica Bertagnolli and Brett Guthrie named Friends 2024 Cancer Leadership Award recipients

YOU MAY BE INTERESTED IN

As Trump’s second term nears, Republican support for NIH is at a low pointBy stonewalling GOP in the House, Biden’s HHS officials eroded bipartisan support for biomedical research

As Trump’s HHS pick, RFK Jr. stands to honor or squander the Kennedy legacy in cancer

What will Trump’s return to the White House mean for oncology?“Our work just got a lot more difficult.”

Trump 2016: A look back at the 45th president’s impact on oncology

New exhibit: Presidential elections and tobacco

How the 2024 elections can impact cancer policy

Never miss an issue!

Login

As Trump’s second term nears, Republican support for NIH is at a low point
By stonewalling GOP in the House, Biden’s HHS officials eroded bipartisan support for biomedical research

What will Trump’s return to the White House mean for oncology?
“Our work just got a lot more difficult.”